This is the published version of a paper published in Virulence.
Citation for the original published paper (version of record):
Bröms, J E., Meyer, L., Sjöstedt, A. (2017)
A mutagenesis-based approach identifies amino acids in the N-terminal part of Francisella tularensis IglE that critically control type VI system-mediated secretion.
Virulence, 8(6): 821-847
https://doi.org/10.1080/21505594.2016.1258507
Access to the published version may require subscription.
N.B. When citing this work, cite the original published paper.
Permanent link to this version:
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141228
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=kvir20
Download by: [Umeå University Library] Date: 06 November 2017, At: 04:28
Virulence
ISSN: 2150-5594 (Print) 2150-5608 (Online) Journal homepage: http://www.tandfonline.com/loi/kvir20
A mutagenesis-based approach identifies amino acids in the N-terminal part of Francisella
tularensis IglE that critically control Type VI system-mediated secretion
Jeanette E. Bröms, Lena Meyer & Anders Sjöstedt
To cite this article: Jeanette E. Bröms, Lena Meyer & Anders Sjöstedt (2017) A mutagenesis- based approach identifies amino acids in the N-terminal part of Francisella tularensis IglE that critically control Type VI system-mediated secretion, Virulence, 8:6, 821-847, DOI:
10.1080/21505594.2016.1258507
To link to this article: http://dx.doi.org/10.1080/21505594.2016.1258507
© 2017 The Author(s). Published with license by Taylor & Francis© Jeanette E.
Bröms, Lena Meyer, and Anders Sjöstedt.
View supplementary material
Accepted author version posted online: 10 Nov 2016.
Published online: 10 Nov 2016.
Submit your article to this journal
Article views: 242 View related articles
View Crossmark data Citing articles: 1 View citing articles
RESEARCH PAPER
A mutagenesis-based approach identi fies amino acids in the N-terminal part of Francisella tularensis IglE that critically control Type VI system-mediated secretion
Jeanette E. Br€oms
y, Lena Meyer
y,z, and Anders Sj€ostedt
Department of Clinical Microbiology, Clinical Bacteriology and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea
University, Umea
, Sweden
ARTICLE HISTORY Received 24 August 2016 Revised 23 October 2016 Accepted 2 November 2016 ABSTRACT
The Gram-negative bacterium Francisella tularensis is the etiological agent of the zoonotic disease tularemia. Its life cycle is characterized by an ability to survive within phagocytic cells through phagosomal escape and replication in the cytosol, ultimately causing in flammasome activation and host cell death. Required for these processes is the Francisella Pathogenicity Island (FPI), which encodes a Type VI secretion system (T6SS) that is active during intracellular infection. In this study, we analyzed the role of the FPI-component IglE, a lipoprotein which we previously have shown to be secreted in a T6SS-dependent manner. We demonstrate that in F. tularensis LVS, IglE is an outer membrane protein. Upon infection of J774 cells, an DiglE mutant failed to escape from phagosomes, and subsequently, to multiply and cause cytopathogenicity. Moreover, DiglE was unable to activate the in flammasome, to inhibit LPS-stimulated secretion of TNF-a, and showed marked attenuation in the mouse model. In F. novicida, IglE was required for in vitro secretion of IglC and VgrG. A mutagenesis-based approach involving frameshift mutations and alanine substitution mutations within the first » 38 residues of IglE revealed that drastic changes in the sequence of the extreme N-terminus (residues 2 –6) were well tolerated and, intriguingly, caused hyper-secretion of IglE during intracellular infection, while even subtle mutations further downstream lead to impaired protein function. Taken together, this study highlights the importance of IglE in F. tularensis pathogenicity, and the contribution of the N-terminus for all of the above mentioned processes.
KEYWORDS
Francisella pathogenicity island; Francisella tularensis;
IglE; type VI secretion
Introduction
Bacteria use secretion systems for transporting a variety of protein substrates across their membranes and into target cells, thereby interfering in various ways with host cell processes. The Type VI Secretion System (T6SS) was first described just 10 y ago, but appears to be ubiqui- tously present in many clinically important Gram-nega- tive pathogens.
1Despite large heterogeneity, re flecting differences in their phylogenetic origin, certain T6SS components are highly conserved, including homologues of Vibrio cholerae IcmF, DotU, ClpV, VipA, VipB, VgrG, and Hcp proteins.
1,2The T6SS performs key roles for the ability of the pathogen to infect eukaryotes and many of the effectors possess enzymatic functions associ- ated with virulence, e.g. phospholipase activity, ADP ribosylation, actin cross-linking, and fusion of eukaryotic membranes.
3-6A feature distinguishing the T6SS from all other bac- terial secretion systems is, however, its central role in interbacterial competition.
7,8Many T6SS-encoded effec- tors are enzymes directed against highly conserved and essential components of bacterial cells, such as the pepti- doglycan layer, bacterial membranes or DNA, thus lead- ing to growth arrest or lysis.
7-12In many cases, antibacterial T6SS effectors occur in tandem with corre- sponding immunity proteins that inhibit the activity of the cognate toxin in the host bacterium, preventing self- damage.
7,9-12Notably, almost all secreted substrates of T6SSs lack classical N-terminal signal peptides,
13and only recently, motifs distinguishing such effectors from other T6S components have been identi fied in a wide variety of Gram-negative bacteria.
14The motifs, denoted
“marker for type 6 effectors (MIX),’ are located predomi- nantly at the N-terminal end of proteins, with predicted
CONTACT Anders Sj€ostedt anders.sjostedt@umu.se Department of Clinical Microbiology, Umea
University, SE-901 85 Umea
, Sweden.
y
These authors equally contributed to this work.
z
Present address: Department of Experimental Medical Science, Section for Immunology, Lund University, Lund, Sweden.
Supplemental data for this article can be accessed on the publisher ’s website .
© 2017 Jeanette E. Br€oms, Lena Meyer, and Anders Sj€ostedt. Published with license by Taylor & Francis.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.